Agree Whatsup , seems a failed IPO can be on sold at a higher price .Seems a bit too convenient to drop it on us for more money when it couldn't raise it's original IPO price .Could still be s good project ?????
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025